Adherence to Highly Active Antiretroviral Therapy (HAART): A Meta-Analysis

被引:244
|
作者
Ortego, Carmen [1 ]
Huedo-Medina, Tania B. [2 ]
Llorca, Javier [3 ,4 ,5 ]
Sevilla, Lourdes [1 ]
Santos, Pilar [1 ]
Rodriguez, Elias [1 ]
Warren, Michelle R. [2 ]
Vejo, Javier [1 ]
机构
[1] Univ Cantabria, Dept Nursing, Santander, Spain
[2] Univ Connecticut, CHIP, Storrs, CT USA
[3] Univ Cantabria, Grp Epidemiol & Computat Biol, Cantabria, Spain
[4] CIBERESP, Barcelona, Spain
[5] IFIMAV, Santander, Spain
关键词
HAART; Acquired immunodeficiency syndrome; HIV; Adherence; Meta-analysis; Human development; HIV-INFECTED PATIENTS; DRUG-RESISTANCE MUTATIONS; SELF-REPORTED ADHERENCE; VIROLOGICAL TREATMENT RESPONSE; QUALITY-OF-LIFE; PATIENT ADHERENCE; PUBLICATION BIAS; TREATMENT SATISFACTION; MEDICATION ADHERENCE; CLINICAL PROGRESSION;
D O I
10.1007/s10461-011-9942-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This meta-analysis synthesizes eighty-four observational studies, conducted across twenty countries, to determine the mean proportion of people who reported >= 90% adherence to prescribed highly active antiretroviral therapy (HAART) and to identify the factors associated with high levels of adherence. Eight electronic databases were searched to locate all relevant studies available by January 2010, which were then coded for sample characteristics and adherence levels. The average rate of reporting >= 90% adherent HAART adherence is 62%. However, this proportion varies greatly across studies. In particular, a greater proportion of individuals maintaining >= 90% adherence to HAART is more likely in studies with higher proportions of men who have sex with men (MSM) and lower proportions of injection drug users (IDU), with participants in an earlier stage of infection, and in studies conducted in countries characterized by lower Human Development Index (HDI) scores.
引用
收藏
页码:1381 / 1396
页数:16
相关论文
共 50 条
  • [31] Effect of highly active antiretroviral therapy (HAART) on cytomegalovirus retinitis
    Guex-Crosier, Y
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1999, 214 (05) : 317 - 320
  • [32] HIV, Highly Active Antiretroviral Therapy (HAART), Pancreatitis: Is There a Relationship?
    Beh, Y.
    Allan, S.
    [J]. DRUG SAFETY, 2012, 35 (10) : 887 - 888
  • [33] Reported adherence as a determinant of response to highly active antiretroviral therapy (HAART) in HIV-infected children
    Van Dyke, RB
    Lee, S
    Stanley, K
    Johnson, GM
    Morse, EV
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 279A - 279A
  • [34] CHANGING TREND IN ADHERENCE TO HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IN THE MULTICENTER AIDS COHORT STUDY.
    Viswanathan, Shilpa
    Detels, Roger
    Macatangay, Bernard J. C.
    Jacobson, Lisa P.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 177 : S66 - S66
  • [35] Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued?
    Bassetti, S
    Battegay, M
    Furrer, H
    Rickenbach, M
    Flepp, M
    Kaiser, L
    Telenti, A
    Vernazza, PL
    Bernasconi, E
    Sudre, P
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (02): : 114 - 119
  • [36] Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART)
    Skiest, DJ
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 317 (05): : 318 - 335
  • [37] Impact of highly active and antiretroviral therapy (HAART) on opportunistic infections
    Currier, J
    [J]. INFECTIONS IN MEDICINE, 1997, 14 : 29 - 30
  • [38] Liposuction for highly active antiretroviral therapy (HAART)-associated lipohypertrophy
    Marco Malahias
    Pambos Lemonas
    Samim Ghorbanian
    Amir Sadri
    Charlie Durrant
    Lucian Ion
    [J]. European Journal of Plastic Surgery, 2012, 35 (1) : 5 - 8
  • [39] Liposuction for highly active antiretroviral therapy (HAART)-associated lipohypertrophy
    Malahias, Marco
    Lemonas, Pambos
    Ghorbanian, Samim
    Sadri, Amir
    Durrant, Charlie
    Ion, Lucian
    [J]. EUROPEAN JOURNAL OF PLASTIC SURGERY, 2012, 35 (01) : 5 - 8
  • [40] AIDS and cancer in the era of highly active antiretroviral therapy (HAART)
    Rabkin, CS
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (10) : 1316 - 1319